Membership
Tour
Register
Log in
John Cogswell
Follow
Person
Plainsboro, NJ, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Treatment of LAG-3 positive tumors
Patent number
11,807,686
Issue date
Nov 7, 2023
Bristol-Myers Squibb Company
James Novotny
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,604,575
Issue date
Mar 31, 2020
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,584,170
Issue date
Mar 10, 2020
Bristol-Myers Squibb Company
John P. Cogswell
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,577,423
Issue date
Mar 3, 2020
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,323,092
Issue date
Jun 18, 2019
Bristol-Myers Squibb Company
John P. Cogswell
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,323,093
Issue date
Jun 18, 2019
Bristol-Myers Squibb Company
John P. Cogswell
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,316,091
Issue date
Jun 11, 2019
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,316,090
Issue date
Jun 11, 2019
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,308,714
Issue date
Jun 4, 2019
Bristol-Myers Squibb Company
John P. Cogswell
G01 - MEASURING TESTING
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,266,596
Issue date
Apr 23, 2019
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,266,594
Issue date
Apr 23, 2019
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,266,595
Issue date
Apr 23, 2019
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,138,299
Issue date
Nov 27, 2018
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
10,072,082
Issue date
Sep 11, 2018
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent number
9,856,320
Issue date
Jan 2, 2018
Bristol-Myers Squibb Company
John P. Cogswell
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Antibodies that bind PD-L1 and uses thereof
Patent number
9,212,224
Issue date
Dec 15, 2015
Bristol-Myers Squibb Company
John Cogswell
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20240417471
Publication date
Dec 19, 2024
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20240034793
Publication date
Feb 1, 2024
Bristol-Myers Squibb Company
John P. COGSWELL
G01 - MEASURING TESTING
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20240002512
Publication date
Jan 4, 2024
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
TREATMENT OF LAG-3 POSITIVE TUMORS
Publication number
20210261666
Publication date
Aug 26, 2021
Bristol-Myers Squibb Company
James NOVOTNY
G01 - MEASURING TESTING
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20200308282
Publication date
Oct 1, 2020
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20190153099
Publication date
May 23, 2019
Bristol-Myers Squibb Company
John P. COGSWELL
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20190135920
Publication date
May 9, 2019
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20190112377
Publication date
Apr 18, 2019
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20190112376
Publication date
Apr 18, 2019
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20190100589
Publication date
Apr 4, 2019
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20190100590
Publication date
Apr 4, 2019
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20190092863
Publication date
Mar 28, 2019
Bristol-Myers Squibb Company
John P. Cogswell
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20180319887
Publication date
Nov 8, 2018
Bristol-Myers Squibb Company
John P. COGSWELL
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20180312590
Publication date
Nov 1, 2018
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20180282413
Publication date
Oct 4, 2018
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20180282414
Publication date
Oct 4, 2018
Bristol-Myers Squibb Company
John P. COGSWELL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20180273624
Publication date
Sep 27, 2018
Bristol-Myers Squibb Company
John P. COGSWELL
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20160090417
Publication date
Mar 31, 2016
Bristol-Myers Squibb Company
JOHN P. COGSWELL
G01 - MEASURING TESTING
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20150125463
Publication date
May 7, 2015
Bristol-Myers Squibb Company
John P. Cogswell
G01 - MEASURING TESTING
Information
Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Publication number
20130309250
Publication date
Nov 21, 2013
John Cogswell
G01 - MEASURING TESTING